GeneDx Holdings Corp. SEC filings WGS

GeneDx Holdings Corp. has 781 filings in SEC EDGAR's recent list, going back to Jul 23, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
10-K Annual report Feb 23, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Feb 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Feb 23, 2024 Dec 31, 2023
ARS Annual report to shareholders May 8, 2023 Dec 31, 2022
10-K Annual report Mar 16, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2022 Dec 31, 2021
10-K/A Amended annual report May 5, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
WGS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Stamford, CT
SEC filer status
Large accelerated filer
SEC CIK
1818331
Former names
Sema4 Holdings Corp. (until Jan 5, 2023); CM Life Sciences, Inc. (until Jul 21, 2021)

Other Services-Health Services companies

All 17 Services-Health Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.